Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Berenberg raises target price on Standard Chartered

(Sharecast News) - Analysts at Berenberg raised their target price on multinational bank Standard Chartered from 1,050.0p to 1,100.0p on Friday after the group's Q1 earnings "validated" management's suggestion that the bank had experienced "an encouraging start" to the year. Berenberg, which has a 'buy' rating on the stock, noted that underlying trends within the business also increased its confidence in the bank's ability to grow revenues year-on-year throughout FY24 and beyond.

Following actions to substantially hedge interest rate risk, the German bank also believes that the sustainability of Standard Chartered's revenues and growth remains poorly appreciated.

"Indeed, lower interest rates may create additional cyclical support. While the shares rose by circa 9% following the Q1 2024 results on 2 May, the bank's 0.6x TBV valuation poorly reflects our FY 2026E RoTE of 12% (in line with guidance). Our new 1,100.0p price target implies circa 50% upside," said Berenberg.

"Our underlying EPS for Standard Chartered increases by 3-5%. We now expect a 12% FY 2026E RoTE and an annual total yield (dividends plus buybacks) of c10-11%. These returns, and Standard Chartered's growth, are poorly reflected in the share price, trading on 0.6x TBV. Our 1,100.0p price target (up from 1,050.0p) values the bank on 0.9x TBV and implies 50% upside."

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Hvivo scores £2.5m contract for Omicron characterisation study
(Sharecast News) - Contract research organisation Hvivo has secured a £2.5m contract with a mid-sized pharmaceutical company to initiate an Omicron characterisation study after the manufacture of its Omicron BA.5 challenge agent was successfully completed in 2023.
MP Evans purchases minority stakes in Indonesian subsidiaries
(Sharecast News) - Palm oil producer MP Evans has purchased a 5% minority holding in the majority of its Indonesian subsidiary trading companies.
JPMorgan upgrades St James's Place, Quilter to 'overweight'
(Sharecast News) - JPMorgan Cazenove upgraded St James's Place and Quilter to 'overweight' from 'neutral' on Monday as it took a look at UK wealth managers.
Shein eyeing potential London listing
(Sharecast News) - Fast fashion retailer Shein will file paperwork for a potential floatation on the London Stock Exchange as soon as this week, according to Sky News, with an initial public offering potentially valuing the firm at roughly £51.7bn.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.